Albuquerque, NM
Migraine Treatment clinics in Albuquerque
Albuquerque has 6 providers offering migraine care, spanning conventional neurology and regenerative or integrative options. The conventional stack includes triptans, CGRP inhibitors like Aimovig, Emgality, Ajovy, and Nurtec ODT, and onabotulinumtoxinA (Botox) for chronic migraine, which is FDA-approved for that indication. On the regenerative and device side, eNeura's sTMS mini is FDA-cleared for acute and preventive treatment of migraine with aura. Occipital and sphenopalatine ganglion nerve blocks are commonly used off-label in Albuquerque clinics, typical cost 150 to 400 dollars per injection. PRP scalp injections and neurofeedback are offered by some integrative practices, though evidence for PRP in migraine is Insufficient. New Mexico insurers generally cover CGRP inhibitors and Botox for chronic migraine (15 or more headache days per month) when step therapy is documented. A reputable Albuquerque migraine clinic will start with a neurology evaluation, headache diary, and imaging when red flags are present before escalating to device or procedural options.
Mind Body Reset Functional Medicine
- IV Therapy
- Migraine Treatment
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
iThrive Infusion and Wellness -IV vitamin infusion
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
- Arthritis Treatment
LUMEN Optimal Wellness
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Arthritis Treatment
- Migraine Treatment
- Red Light Therapy
Regulatory context
A note on New Mexico's migraine treatment rules.
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
-
New Mexico Medical Practice Act (NMSA 61-6-1 et seq.)
Defines the practice of medicine and supervision framework for delegated procedures including TMS technician work. -
New Mexico Professional Psychologist Act (NMSA 61-9-1 et seq.)
Governs licensed psychologists who deliver biofeedback and neurofeedback within scope. -
New Mexico Prescribing Psychologist Act (NMSA 61-9-17.2)
Authorizes appropriately trained psychologists to prescribe, which may affect supervision of adjunct neuromodulation.
The New Mexico Medical Board investigates TMS clinics for supervision lapses and off-label marketing. The New Mexico attorney general enforces the Unfair Practices Act against deceptive medical device advertising, including neurofeedback cure claims. Wellness clinics in Santa Fe and Albuquerque that offer CES or tDCS face scrutiny when marketing implies FDA-cleared medical treatment. Commercial insurers and New Mexico Medicaid typically require documented treatment-resistant depression before covering TMS for major depressive disorder.